HGHCX — The Hartford Healthcare Fund
Data updated: 2026-06-25
HGHCX — The Hartford Healthcare Fund. United States Large Cap Blend / Core Health Care Equity · $729.19M AUM. Holdings, fees, performance and SEC filings.
HGHCX Fund Overview
HGHCX — The Hartford Healthcare Fund is a US mutual fund managed by Hartford Mutual Funds, INC, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Hartford Mutual Funds, INC
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $729.19M
- 1-year return: 11.0%
- Ticker: HGHCX
- SEC CIK: 0001006415
- SEC series ID: S000003576
- Share class ID: C000009934
HGHCX Holdings
Top 10 holdings of The Hartford Healthcare Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co | 12.11% |
| Merck & Co Inc | 6.30% |
| Johnson & Johnson | 5.81% |
| UnitedHealth Group Inc | 5.54% |
| Intuitive Surgical Inc | 3.62% |
| AbbVie Inc | 3.09% |
| Abbott Laboratories | 2.80% |
| Danaher Corp | 2.68% |
| Edwards Lifesciences Corp | 2.54% |
| CVS Health Corp | 2.44% |
HGHCX Portfolio Allocation
Asset-class allocation of The Hartford Healthcare Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.4% |
| Cash & Equivalents | 0.5% |
HGHCX Performance
Total returns for HGHCX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -4.6% |
| 1 year | 11.0% |
| 3 years (annualised) | 3.8% |
| 5 years (annualised) | 0.6% |
HGHCX Risk Information
Risk metrics for HGHCX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.5%
HGHCX Costs and Fees
HGHCX costs about $212 per $10,000 invested per year in fund expenses.
- Net expense ratio: 2.12%
- Gross expense ratio: 2.12%
- Portfolio turnover: 23%
- Brokerage commissions: 4.11 bps of average net assets (SEC N-CEN)
HGHCX Cashflows
Over the 12 months to 2026-04, The Hartford Healthcare Fund had net outflows of $189.99M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$15.32M |
| 2026-03 | −$46.93M |
| 2026-02 | −$11.05M |
| 2026-01 | −$7.38M |
| 2025-12 | $16.11M |
| 2025-11 | −$10.29M |
HGHCX Debt Constituents
No individual debt constituents are reported in The Hartford Healthcare Fund's latest SEC N-PORT filing.
HGHCX Prospectus and SEC Filings
Official The Hartford Healthcare Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-02-26
- Prospectus (485BPOS) — filed 2025-02-27
- Prospectus (485BPOS) — filed 2024-02-28
- Portfolio holdings (N-PORT) — filed 2026-06-25
- Portfolio holdings (N-PORT) — filed 2026-03-25
- Portfolio holdings (N-PORT) — filed 2025-12-17
- Annual census (N-CEN) — filed 2026-01-13
- Annual census (N-CEN) — filed 2025-01-13
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.